Reference : Pilot study of milnacipran in panic disorder
Scientific journals : Article
Social & behavioral sciences, psychology : Theoretical & cognitive psychology
http://hdl.handle.net/2268/259596
Pilot study of milnacipran in panic disorder
English
ANSSEAU, Marc mailto [Université de Liège - ULg]
von Frenckell, Rémy [Psychiatric Unit, Centre Hospitalier Universitaire de Liege, Domaine Universitaire du Sart Tilman, B-4000 Liege 1, Belgium]
Serre, Christiane [Psychiatric Unit, Centre Hospitalier Universitaire de Liege, Domaine Universitaire du Sart Tilman, B-4000 Liege 1, Belgium]
1991
European Psychiatry
Elsevier Masson
6
2
103-105
Yes (verified by ORBi)
International
0924-9338
1778-3585
Paris
France
[en] Panic disorder ; Milnacipran
[en] Ten outpatients with panic disorder were treated over an 8 week-period with milnacipran, an antidepressant active on both noradrenergic and serotonergic systems, at a dose between 100 and 150 mg/d. Clinical assessments included the Hamilton Anxiety Scale and the Cottraux Rating Scale for phobias, panic attacks, and generalized anxiety. Results showed very significant improvements in the frequency and intensity of panic attacks, and in the level of generalized anxiety. A good or excellent response was noted in 7 patients. Only 3 patients complained of side-effects, mostly of the digestive type. These promising results of milnacipran in panic disorder need to be confirmed in controlled studies.
Researchers ; Professionals ; Students
http://hdl.handle.net/2268/259596

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
Pilot study of milnacipran in panic disorder.pdfPublisher postprint2.18 MBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.